[go: up one dir, main page]

EP0684828A4 - Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta. - Google Patents

Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta.

Info

Publication number
EP0684828A4
EP0684828A4 EP94910691A EP94910691A EP0684828A4 EP 0684828 A4 EP0684828 A4 EP 0684828A4 EP 94910691 A EP94910691 A EP 94910691A EP 94910691 A EP94910691 A EP 94910691A EP 0684828 A4 EP0684828 A4 EP 0684828A4
Authority
EP
European Patent Office
Prior art keywords
tgf
neutralization
expansion
stem cells
bone marrow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94910691A
Other languages
German (de)
English (en)
Other versions
EP0684828A1 (fr
Inventor
Wendy Waegell
James Dasch
Paul W Kincade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma Medical Research Foundation
Celtrix Pharmaceuticals Inc
Original Assignee
Oklahoma Medical Research Foundation
Celtrix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation, Celtrix Pharmaceuticals Inc filed Critical Oklahoma Medical Research Foundation
Publication of EP0684828A1 publication Critical patent/EP0684828A1/fr
Publication of EP0684828A4 publication Critical patent/EP0684828A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP94910691A 1993-02-19 1994-02-15 Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta. Withdrawn EP0684828A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1955693A 1993-02-19 1993-02-19
US19556 1993-02-19
PCT/US1994/001634 WO1994018991A1 (fr) 1993-02-19 1994-02-15 Expansion de cellules souches dans les cultures sur une longue duree de m×lle osseuse par neutralisation du facteur de croissance transformant beta

Publications (2)

Publication Number Publication Date
EP0684828A1 EP0684828A1 (fr) 1995-12-06
EP0684828A4 true EP0684828A4 (fr) 1996-08-07

Family

ID=21793831

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94910691A Withdrawn EP0684828A4 (fr) 1993-02-19 1994-02-15 Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta.

Country Status (4)

Country Link
EP (1) EP0684828A4 (fr)
JP (1) JPH08509859A (fr)
CA (1) CA2155515A1 (fr)
WO (1) WO1994018991A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571714A (en) * 1988-12-22 1996-11-05 Celtrix Pharmaceuticals, Inc. Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
WO1994009815A1 (fr) * 1992-10-29 1994-05-11 Celtrix Pharmaceuticals, Inc. UTILISATIONS D'UN FRAGMENT DE RECEPTEUR DU TGF-β COMME AGENT THERAPEUTIQUE
JP4531132B2 (ja) * 1995-06-02 2010-08-25 ギリード・サイエンシズ・インコーポレーテッド 増殖因子に対する高親和性オリゴヌクレオチドリガンド
US5728581A (en) * 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
AU2737500A (en) * 1999-01-25 2000-08-07 Seattle Biomedical Research Institute Anti-transforming growth factor beta (tgf-beta) treated stem cell composition and method
MXPA06011199A (es) 2004-03-31 2007-04-16 Genentech Inc Anticuerpos anti-tgf-beta humanizados.
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US20150064273A1 (en) 2012-02-13 2015-03-05 Gamida-Cell Ltd. Mesenchymal Stem Cells Conditioned Medium and Methods of Generating and Using the Same
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0455482A2 (fr) * 1990-05-01 1991-11-06 Becton, Dickinson and Company Subliguée de cellules progénitrices humaines
WO1991019513A1 (fr) * 1990-06-20 1991-12-26 Bristol-Myers Squibb Company PROCEDES DE MODULATION DE LA PRESSION SANGUINE A L'AIDE DU FACTEUR TRANSFORMANT DE CROISSANCE-β ET DE SES ANTAGONISTES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0455482A2 (fr) * 1990-05-01 1991-11-06 Becton, Dickinson and Company Subliguée de cellules progénitrices humaines
WO1991019513A1 (fr) * 1990-06-20 1991-12-26 Bristol-Myers Squibb Company PROCEDES DE MODULATION DE LA PRESSION SANGUINE A L'AIDE DU FACTEUR TRANSFORMANT DE CROISSANCE-β ET DE SES ANTAGONISTES

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9418991A1 *
WAEGELL W.O. ET AL: "Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta", EXPERIMENTAL HEMATOLOGY, vol. 22, October 1994 (1994-10-01), NEW YORK, pages 1051 - 1057, XP000572237 *

Also Published As

Publication number Publication date
CA2155515A1 (fr) 1994-09-01
EP0684828A1 (fr) 1995-12-06
JPH08509859A (ja) 1996-10-22
WO1994018991A1 (fr) 1994-09-01

Similar Documents

Publication Publication Date Title
EP0812201A4 (fr) Amplification in vitro de cellules souches
IL107483A0 (en) Bone marrow transplantation
FI962349L (fi) Luun morfogeneettisten proteiinien mutantit
EP0630625A3 (fr) Implant pour remplacer des corps vertébraux.
EP0171176A3 (en) Bone repair using collagen
AU7232094A (en) Bone fixation system
GB8500644D0 (en) Implant in bones
AU3142795A (en) Human marrow stromal cell lines which sustain hematopoiesis
GB8409714D0 (en) Hip implant
AU6039696A (en) Myogenic differentiation of human mesenchymal stem cells
GB9508033D0 (en) Improvements in or relating to bone support
IL106278A0 (en) Bone formation-inducing protein
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
GB8426866D0 (en) Bone implants
EP0684828A4 (fr) Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta.
GB9020035D0 (en) Bone implant
GB9608211D0 (en) Bone implants
EP0652703A4 (fr) Methodes d'immunoselection positive de cellules souches.
IL118590A0 (en) Methods for minimizing bone loss
EP0662512A3 (fr) Cellules souches hématopoiétiques humaines.
ZA921099B (en) Method of lyophilization of mammalian sperm cells
FI960064A7 (fi) Uudet peruskudoksen solulinjat ihmisen luuytimestä ja niiden käyttö
EP0711111A4 (fr) Nouveau marqueur de cellules souche
GB9605308D0 (en) Sertoli cells as transplantation facilitator for cell transplatation
GB9125052D0 (en) Culture of bone cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950825

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE ES FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 19960619

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE ES FR GB IT

17Q First examination report despatched

Effective date: 19980901

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990312